HeartSciences (HSCS) Debt Ratio (2022 - 2025)

HeartSciences' (HSCS) quarterly Debt Ratio came in at 0.49 in Q2 2025, up 7536.13% on a QoQ basis from 0.01 in Q4 2024.

HeartSciences (HSCS) Debt Ratio (2022 - 2025) Analysis & Trends

HeartSciences (HSCS) has 4 years of Debt Ratio data on file, last reported at 0.49 in Q2 2025.

Quarterly Debt Ratio changed N/A year-over-year to 0.49 in Q2 2025, while the trailing twelve-month figure through Apr 2025 was 0.49 (changed N/A YoY) and the FY2025 annual result came in at 0.49, changed N/A from the prior year.
Debt Ratio grew to 0.49 in Q2 2025, from 0.01 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 2.13 in Q2 2022 to a low of 0.01 in Q4 2024.
A 4-year average of 0.44 and a median of 0.19 in 2023 frame the typical range for Debt Ratio.
The widest YoY moves for Debt Ratio: up 7.15% in 2023, down 92.84% in 2023.
Tracing HSCS's Debt Ratio over 4 years: stood at 0.18 in 2022, then advanced by 7.15% to 0.19 in 2023, then tumbled by 96.7% to 0.01 in 2024, then jumped by 7536.13% to 0.49 in 2025.
The last three Debt Ratio figures came in at 0.49 (Q2 2025), 0.01 (Q4 2024), and 0.06 (Q3 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	202.39 Bn	196.79 Bn	7.27 Bn	0.30
2	Stryker	126.37 Bn	122.89 Bn	4.50 Bn	0.31
3	Medtronic	119.28 Bn	110.06 Bn	6.41 Bn	0.30
4	Boston Scientific	74.16 Bn	73.63 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.65 Bn	47.40 Bn	1.35 Bn	0.04
6	Dexcom	35.04 Bn	33.10 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.20 Bn	22.88 Bn	4.55 Bn	0.28
9	Steris	23.16 Bn	22.68 Bn	684.20 Mn	0.18
10	HeartSciences	7.11 Mn	5.41 Mn	-	-

Download Data